Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin
Journal
Antibiotics (Basel, Switzerland)
Journal Volume
11
Journal Issue
5
Date Issued
2022-04-25
Author(s)
Yang, Jeng-How
Wang, Ping-Huai
Pan, Sheng-Wei
Wei, Yu-Feng
Lee, Ho-Sheng
Wu, Ting-Shu
Abstract
The contemporary guidelines have recommended multiple antimicrobial therapies along with oral macrolides for the treatment of Mycobacterium abscessus complex lung disease (MABC-LD). However, there is little evidence supporting the parenteral tigecycline-containing regimens against MABC-LD. Therefore, we conducted this study to evaluate the effect of intravenous tigecycline-containing regimens on the treatment of MABC-LD.
Subjects
Mycobacterium abscessus complex; amikacin; lung disease; tigecycline; treatment outcome
SDGs
Publisher
MDPI
Type
journal article